Roche Coronavirus Test

FDA grants Emergency Use

The FDA has issued an Emergency Use Authorization for Roche’s (OTCQX:RHHBY) fully automated cobas SARS-CoV-2 Test for the qualitative (yes or no answer) detection of the coronavirus causing the current outbreak COVID-19. The test, also available in markets accepting the CE Mark, is performed on nasopharyngeal and oropharyngeal swab samples. The company says it has the capacity to perform “millions” of tests per month on its cobas 6800 and 8800 analyzers.

Leave a Reply

Your email address will not be published. Required fields are marked *